QTNT News
Archived Headlines
- 4 US IPOs planned for the week of Apr 21 04/21/14
- Blood test developer Quotient decreases range to $9 to $11; cuts deal size by 33% 04/14/14
- 11 US IPOs planned for the week of Apr 14 04/14/14
- Blood test provider Quotient sets terms for $75 million IPO 04/03/14
- US IPO Recap: Coupons.com jumps 88% and Biomet files for an IPO 03/10/14
See more
It's not lupus: Exagen Diagnostics files for a $69 million IPO
Exagen Diagnostics, which sells diagnostic blood tests that detect lupus and rheumatoid arthritis, filed on Friday with the SEC to raise up to $69 million in an initial public offering. Primary shareholders include Sun Mountain Capital, Tullis Health...read more
Diagnostics developer T2 Biosystems files for a $69 million IPO
T2 Biosystems, which is developing diagnostics tests that screen for sepsis and hemostasis, filed on Wednesday with the SEC to raise up to $69 million in an initial public offering. The company claims that its technology platform will lead to an earlier...read more
Quotient prices IPO at $8
Quotient, which is developing a diagnostics test for grouping and disease screening blood samples, raised $40 million by offering 5.0 million shares at a price of $8, along with attached warrants to purchase 4 million shares at $8.80 per share. The company had...read more
Quotient cuts proposed range and adds warrants
Quotient, which is developing a diagnostics test for grouping and disease screening blood samples, lowered the proposed deal size for its upcoming IPO on Wednesday. The Midlothian, United Kingdom-based company now plans to raise $40 million by offering 5.0...read more